AstraZeneca completes sale of Zeneca specialities
ASTRAZENECA COMPLETES SALE OF ZENECA SPECIALITIES
AstraZeneca today completed the previously announced sale of its Zeneca
Specialities business for a cash amount of $2.1 billion (£1.3) in a buyout
jointly financed by Cinven and Investcorp.
Steve Brown, Media Relations Manager, tel +44 171 304 5033